Bone lengthening using the Fitbone^® motorized intramedullary nail: The first experience in France

详细信息    查看全文

• 作者：F. Accadbled^a ; R. Pailhé ; ^b ; ^{regis.pailhe@doctors.org.uk" class="auth_mail" title="E-mail the corresponding author} ; E. Cavaignac^a ; J. Sales de Gauzy^a
• 关键词：Motorized nail ; Length discrepancy ; Bone lengthening ; Fitbone®
• 刊名：Orthopaedics & Traumatology: Surgery & Research
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：102
• 期：2
• 页码：217-222
• 全文大小：1049 K

文摘

Intramedullary limb lengthening systems include mechanical systems (the Albizzia nail and the ISKD nail) as well as motorized systems with the Fitbone^® (Wittenstein, Igersheim, Germany) and the Precice^® (Ellipse Technologies, Irvine, CA, USA) nails. We hypothesized that limb lengthening using the Fitbone^® nail was reliable, reproducible, and comfortable for the patient.

Patients and methods

Between 2010 and 2013, a prospective single-center, single-operator (FA) study was conducted on patients who had undergone limb lengthening using the Fitbone^® nail. The inclusion criteria were length discrepancy of the limbs equal to or greater than 25 mm or a short stature. The exclusion criteria were indications for cosmetic reasons and/or growth plates that were still open. The lengthening parameters were assessed postoperatively and at the last follow-up. Lengthening was considered achieved when the lengthening objective did not differ by more than 5 mm. All complications were noted. A statistical analysis was performed.

Results

Twenty-six Fitbone^® nails were implanted in 23 patients, in the femur in 15 cases and the tibia in 11 cases. The patients’ mean age was 22.5 years (range: 15–53 years) and the mean follow-up was 3.4 years (range: 2–5.3 years). The limb lengthening targeted was obtained in 23 cases (88%) and the mean lengthening was 45.3 ± 18 mm (range: 20–80 mm). The mean time to healing was 277 ± 167 days (range: 86–638 days). The mean healing index was 73 ± 57 days/cm for the femurs and 83.5 ± 65 days/cm for the tibias. The mean complication rate was 15.4%.

Discussion

This study emphasizes the good short-term results of this motorized intramedullary lengthening system. An evaluation over the longer term and with a higher number of patients remains necessary.

Level of evidence

IV: uncontrolled, prospective, continuous study.